Drug Therapy
Conference Coverage
Updated systematic review of aspirin primary prevention shows benefits, risks
News
Opioid prescriptions declined 33% over 5 years
The number of opioid prescriptions decreased 33% nationally from 2013 to 2018, according to the new report from the American Medical Association...
Outcomes Research in Review
Once-Daily 2-Drug versus 3-Drug Antiretroviral Therapy for HIV Infection in Treatment-naive Adults: Less Is Best?
Original Research
Mismatch Between Process and Outcome Measures for Hospital-Acquired Venous Thromboembolism in a Surgical Cohort
Clinical Review
Chronic Myeloid Leukemia: Selecting First-line TKI Therapy
Conference Coverage
Meta-analysis finds no link between PPI use and risk of dementia
SAN DIEGO – In the absence of randomized trial evidence, a PPI prescribing approach based on appropriate use appears sufficient.
FDA/CDC
Cannabis: Doctors tell FDA to get out of the weeds
Unregulated use of cannabidiol was the chief concern of many physicians.
News
Studies cast doubt on FDA’s accelerated cancer drug pathway
An analysis suggests cancer drugs approved based on response rate often have no confirmed clinical benefit, while another finds only one-fifth of...
FDA/CDC
FDA grants Priority Review to Vascepa for cardiovascular risk reduction
The Food and Drug Administration has granted a Priority Review to the supplemental new drug application for icosapent ethyl (Vascepa).
Conference Coverage
Synthetic drugs pose regulatory, diagnostic challenges
SAN FRANCISCO – Every year brings about 250 novel recreational drugs.